4.2 Article

Metabolomics study on the therapeutic effect of the Chinese herb pair Fructus Aurantii Immaturus and Rhizoma Atractylodis Macrocephalae in constipated rats based on UPLC-Q/TOF-MS analysis

Journal

ANNALS OF PALLIATIVE MEDICINE
Volume 9, Issue 5, Pages 2837-2852

Publisher

AME PUBL CO
DOI: 10.21037/apm-20-280

Keywords

Aurantii Fructus Immaturus; Atractylodis Macrocephalae Rbizoma; herb pair; slow transit constipation (STC)

Funding

  1. China Postdoctoral Science Foundation [2017M620220]
  2. technology project of Jiangsu Provincial Administration of Traditional Chinese Medicine [YB2017061]
  3. Scientific Foundation of Integrated traditional Chinese and Western Medicine of Suzhou [SYSD2018212]
  4. Young Elite Scientists Sponsorship Program by China Association of Chinese Medicine [CACM-2018-QNRC2-C13]
  5. Open Project Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica [JKLPSE201819]
  6. Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
  7. fifth batch of Gusu health personnel training project in Suzhou [GSWS2019065]
  8. Suzhou Science and Technology Development Plan people's livelihood Science and Technology - Research on the Application of key Technologies [SS2019073]

Ask authors/readers for more resources

Background: In China, Zhishi (Aurantii Fructus Immaturus) - Baizhu (Atractylodis Macrocephalae Rhizoma) is a well-known herb pair used to treat gastrointestinal motility disorders for thousands of years, and it has especially shown a definite advantage in the treatment of slow transit constipation (STC). However, the mechanism of Zhishi-Baizhu (ZSBZ) in the treatment of STC remains unclear. In this study, plasma metabolomics research combined with metabolic pathway analysis has been used to illuminate the potential mechanism of its effects against STC. Methods: Parameters of intestinal transit ratio, plasma motilin (MTL), substance P (SP), adenosine triphosphate (ATP), histological alteration of the colon and MLCK expression in the colon were detected to evaluate the effects with respect to STC. Principal component analysis (PCA) was used to investigate the global metabolite alterations, while orthogonal partial least squares discriminant analysis (OPLS-DA) and t-test were used to filter potential metabolite markers. Moreover, metabolic pathway analysis was employed. Results: Oral administration of ZSBZ significantly prevented the development of STC. Results: It increased the expression of MTL and SP in serum, as well as the expression of ATP and MLCK in the colon. ZSBZ administration alleviated symptoms in loperamide-induced constipated rats, evidenced by the increase of intestinal transit ratio. Futhermore, 9 potential biomarkers of STC were screened, and the levels were all reversed to different degrees after ZSBZ administration. Metabolic pathway analysis showed that the improvement of STC by ZSBZ was mainly related to caffeine and vitamin B6 metabolism. Conclusions: Our study identifies the metabolic networks of constipated rats and demonstrates the efficacy of this metabolomics approach to systematically study the therapeutic effects of ZSBZ on constipation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available